Vermillion (VRML - Get Report) is engaged in the discovery, development and commercialization of diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. This stock is trading up 6% at $1.69 in recent trading.
Today's Range: $1.55-$1.8552-week Range: $1.17-$9.49 Volume: 254,605 Three-Month Average Volume: 148,789 This stock is trending higher today after the company reported a $4.7 million net loss on $320,000 in revenue in the third quarter, vs. a $2.7 million loss on $413,000 in revenue during the same period last year. >>20 Highest-Yielding Drug Stocks From a technical standpoint, this stock has been stuck in a nasty downtrend for the past six months, with shares making mostly lower highs and lower lows. The stock is also currently trading well below both its 50-day and 200-day moving averages, which is bearish. That said, traders can look to play the next major breakout that will trigger on a high-volume move above $2 and then $2.25. If we see that action soon, look for a run back towards $3.